AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2018
Feb 14, 2018
30237_dirs_2018-02-14_c9ee6bbf-940e-4588-9a00-260ee6ec99ab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2018-02-12
Reporting Person: KING DAVID P (Director, President & CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-12 | Restricted Stock Unit | $ | A | 10540 | Acquired | Common Stock (10540) | Direct | |
| 2018-02-12 | Non-qualified Stock Options | $168.49 | A | 41000 | Acquired | 2028-02-11 | Common Stock (41000) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2019.
F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F4: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F5: The option vests in three equal installments beginning on the date reflected in this column.